PD

Poonam Duggal

Active Director Designated Partner DIN 10622035
DIN 10622035 First appointment May 2024 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Poonam Duggal

Data last updated:

Poonam Duggal is a Designated Partner at Amgenic Healthcare Llp (since 2024). The company operates in Healthcare.

DIN 10622035
Primary Designation Designated Partner
Industry Healthcare
First Appointment 24 May 2024
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner24 May 20242020Active

Board colleagues of Poonam Duggal

NameDINCompanyDesignation
Muskaan Duggal10622046Amgenic Healthcare LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Amgenic Healthcare Llp
Premium access

Shareholding and investment profile for Poonam Duggal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Poonam Duggal

Poonam Duggal currently holds 1 directorship: Amgenic Healthcare Llp (Designated Partner, since 24 May 2024).

Poonam Duggal was first appointed on 24 May 2024 as Designated Partner at Amgenic Healthcare Llp.

The current boards of Poonam Duggal's companies include Muskaan Duggal (Amgenic Healthcare Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available